IPX | IperionXNASDAQADR golden cross and death cross projections, cross tests and history

$15.00
-$0.01 (-0.07%)

IperionX (IPX) is a NASDAQ-listed ADR that Cruxta has tracked for 50/200 crosses since 2023.

The 50 SMA has sat below the 200 on the daily since Apr 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 2 Nov 16:00 ET

Price
below both $15.00 vs 50 $17.88 / 200 $30.16
Projection
No cross projected
Test
No active test
Last cross
Death cross 7 Apr 2026 ยท projected 21 bars out

Weekly as of 30 Oct 16:00 ET

Price
below both $15.01 vs 50 $31.06 / 200 $21.63
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 16:00 ET

Price
below both $14.89 vs 50 $15.00 / 200 $21.53
Projection
No cross projected
Test
No active test
Last cross
Death cross 16 Jun 2026 ยท not projected

Cross history

14
crosses on record since 2023
6 golden8 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
16 Jun 2026Death4-hournot projectedNot tested
10 Jun 2026Golden4-hour26 bars out1 bar cross test
7 Apr 2026Death steepdaily21 bars outNot tested
24 Mar 2026Death4-hour22 bars outNot tested
27 Jan 2026Golden4-hour30 bars outNot tested

About IPX

ExchangeNASDAQ
InstrumentADR
Median $ volume, 60 d$4.7M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.